LYZL6 inhibitors are a class of chemical compounds specifically designed to target and modulate the activity of the Lysozyme-like 6 (LYZL6) enzyme. LYZL6 is a member of the Lysozyme-like protein family, which shares structural similarities with the classical lysozyme enzyme. These inhibitors are meticulously crafted molecules that play a crucial role in biological research and drug development due to their ability to interact with LYZL6, a protein that is implicated in various cellular processes.
The primary function of LYZL6 inhibitors is to bind to the LYZL6 enzyme, altering its catalytic activity or overall function within the cell. By doing so, these inhibitors can help researchers elucidate the precise roles of LYZL6 in cellular processes and signaling pathways. Understanding the functions and mechanisms of LYZL6 can provide valuable insights into its involvement in various physiological and pathological processes. Additionally, LYZL6 inhibitors can serve as valuable tools for drug discovery and development by providing a means to manipulate LYZL6 activity and identify new targets or pathways. Researchers employ these inhibitors in laboratory settings to investigate the implications of modulating LYZL6 in various biological contexts, shedding light on its role in health and disease.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
LY2157299 | 700874-72-2 | sc-391123 sc-391123A | 5 mg 10 mg | $213.00 $359.00 | 3 | |
LY2157299 inhibits lysyl oxidase-like 2 (LOXL2), an enzyme involved in extracellular matrix remodeling, by disrupting its activity, which may impede fibrosis and tumor progression. | ||||||
Ciclopirox | 29342-05-0 | sc-217893 | 25 mg | $207.00 | 2 | |
Ciclopirox inhibits LOX activity, reducing collagen cross-linking, and potentially affecting fibrosis. | ||||||
Dansylcadaverine | 10121-91-2 | sc-214851 sc-214851A sc-214851B | 100 mg 250 mg 1 g | $52.00 $89.00 $240.00 | 4 | |
A competitive inhibitor of LOX, Dansylcadaverine interferes with the cross-linking of collagen and elastin fibers. | ||||||
JNJ 26854165 | 881202-45-5 | sc-364514 sc-364514A | 5 mg 25 mg | $171.00 $577.00 | ||
Serdemetan is a small molecule inhibitor of lysyl oxidase homolog 2 (LOXL2), targeting fibrosis by blocking collagen cross-linking. | ||||||